Cargando…

Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety

Twenty-five years have passed since the discovery of the orexin system, during which time we have learned more and more about it. A number of studies have been conducted showing the role of the orexin system in insomnia, as well as its potential use in the treatment of obesity and depression. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziemichód, Wojciech, Kurowska, Antonina, Grabowska, Karolina, Kurowska, Michalina, Biała, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142100/
https://www.ncbi.nlm.nih.gov/pubmed/37110810
http://dx.doi.org/10.3390/molecules28083575
_version_ 1785033533404741632
author Ziemichód, Wojciech
Kurowska, Antonina
Grabowska, Karolina
Kurowska, Michalina
Biała, Grażyna
author_facet Ziemichód, Wojciech
Kurowska, Antonina
Grabowska, Karolina
Kurowska, Michalina
Biała, Grażyna
author_sort Ziemichód, Wojciech
collection PubMed
description Twenty-five years have passed since the discovery of the orexin system, during which time we have learned more and more about it. A number of studies have been conducted showing the role of the orexin system in insomnia, as well as its potential use in the treatment of obesity and depression. In this review, we present the role of the orexin system in the development of depressive illness and show the characteristics of seltorexant, a potential drug for the treatment of depression. This review describes the structure and synthesis of the compound as well as its pharmacodynamics and pharmacokinetics. Pre-clinical and clinical studies are also described, including side effects. There is evidence that the use of seltorexant is considered safe, with no clear or major clinically significant side effects, which makes it a promising candidate for the treatment of depression and anxiety disorders.
format Online
Article
Text
id pubmed-10142100
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101421002023-04-29 Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety Ziemichód, Wojciech Kurowska, Antonina Grabowska, Karolina Kurowska, Michalina Biała, Grażyna Molecules Review Twenty-five years have passed since the discovery of the orexin system, during which time we have learned more and more about it. A number of studies have been conducted showing the role of the orexin system in insomnia, as well as its potential use in the treatment of obesity and depression. In this review, we present the role of the orexin system in the development of depressive illness and show the characteristics of seltorexant, a potential drug for the treatment of depression. This review describes the structure and synthesis of the compound as well as its pharmacodynamics and pharmacokinetics. Pre-clinical and clinical studies are also described, including side effects. There is evidence that the use of seltorexant is considered safe, with no clear or major clinically significant side effects, which makes it a promising candidate for the treatment of depression and anxiety disorders. MDPI 2023-04-19 /pmc/articles/PMC10142100/ /pubmed/37110810 http://dx.doi.org/10.3390/molecules28083575 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ziemichód, Wojciech
Kurowska, Antonina
Grabowska, Karolina
Kurowska, Michalina
Biała, Grażyna
Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
title Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
title_full Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
title_fullStr Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
title_full_unstemmed Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
title_short Characteristics of Seltorexant—Innovative Agent Targeting Orexin System for the Treatment of Depression and Anxiety
title_sort characteristics of seltorexant—innovative agent targeting orexin system for the treatment of depression and anxiety
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142100/
https://www.ncbi.nlm.nih.gov/pubmed/37110810
http://dx.doi.org/10.3390/molecules28083575
work_keys_str_mv AT ziemichodwojciech characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety
AT kurowskaantonina characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety
AT grabowskakarolina characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety
AT kurowskamichalina characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety
AT białagrazyna characteristicsofseltorexantinnovativeagenttargetingorexinsystemforthetreatmentofdepressionandanxiety